Search

Lilly, Pfizer-backed Arkuda bags $64M to test drug in frontotemporal dementia in 2023

Read More

Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning

Read More

Engitix Nets $54M for Human Extracellular Matrix Drug Targets

Read More

Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2o

Read More

Lucy Therapeutics Expands Cutting-Edge Medical Research Program

Read More

Satellite Bio lifts off with $110M to fuel development of its implantable tissue therapies

Read More

Gilead joins a lineup of Big Pharma partners betting big on TriNKETs, with a $300M cash ante to get started on a 5T4

Read More

Amgen-backed Kernal Biologics pops off with $25M for mRNA platform

Read More

Nanopath is looking to drastically change medical diagnostics

Read More

PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment

Read More